Regulus Therapeutics
RGLS
#9072
Rank
C$0.13 B
Marketcap
$2.13
Share price
7.25%
Change (1 day)
-35.28%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$9.99 Million

According to Regulus Therapeutics's latest financial reports the company's total liabilities are C$9.99 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$12.68 M-30.37%
2022-12-31C$18.21 M5.91%
2021-12-31C$17.19 M16.51%
2020-12-31C$14.76 M-48.78%
2019-12-31C$28.81 M-37.37%
2018-12-31C$46.01 M-14.07%
2017-12-31C$53.55 M-10.63%
2016-12-31C$59.91 M154%
2015-12-31C$23.58 M-48.49%
2014-12-31C$45.79 M45.31%
2013-12-31C$31.51 M-23.49%
2012-12-31C$41.19 M-52%
2011-12-31C$85.82 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$83.62 B 836,332.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$82.15 B 821,578.64%๐Ÿ‡ซ๐Ÿ‡ท France
C$16.28 B 162,781.58%๐Ÿ‡บ๐Ÿ‡ธ USA
C$90.76 B 907,689.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$5.99 B 59,872.55%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.10 B 936.63%๐Ÿ‡บ๐Ÿ‡ธ USA
C$109.51 B 1,095,257.86%๐Ÿ‡บ๐Ÿ‡ธ USA